📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A candidate vaccine for human visceral leishmaniasis based on a specific T cell epitope-containing chimeric protein protects mice against Leishmania infantum infection. (2020)

First Author: Lage DP

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41541-020-00224-0

PubMed Identifier: 32821440

Publication URI: http://europepmc.org/abstract/MED/32821440

Type: Journal Article/Review

Volume: 5

Parent Publication: NPJ vaccines

ISSN: 2059-0105